Biogen Inc. buy Royal Bank of Canada
Start price
01.08.25
/
50%
€114.05
Target price
01.08.26
€191.89
Performance (%)
11.14%
Price
15:27
€126.75
Summary
This prediction is currently active. The prediction currently has a performance of 11.14%. This prediction currently runs until 01.08.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 0.639% | 0.639% |
| iShares Core DAX® | 0.299% | 2.868% |
| iShares Nasdaq 100 | 2.257% | 3.363% |
| iShares Nikkei 225® | 5.054% | 8.119% |
| iShares S&P 500 | 1.414% | 2.409% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank Of Canada from $208.00 to $219.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat